Annually, urinary tract infections (UTIs) are responsible for more than 11 million physician visits in the United States. Although normally a commensal inhabitant of the intestinal and gastrointestinal tract of humans, Escherichia coli is the most common urinary-tract pathogen, whose overgrowth and overcolonization accounts for 85% of UTIs. Cranberries have been used as a medicinal agent for centuries to promote health, but recently the scientific literature has proven that proanthocyanidins, contained in cranberries, as well as a simple sugar, á´…â€‘mannose, specifically inhibit the adhesion and proliferation of E. coli in the urinary tract. Cranberry extracts and á´…â€‘mannose each independently inhibit one of two adhesion methods utilized by E. coli. Combined together in a synergistic and novel formula, Dâ€‘Mannose SAP addresses both type-1 (FimH) and P-type fimbrial-mediated adhesion by E. coli to the urinary tract mucosa. Dâ€‘Mannose SAP is specifically targeted for the treatment and prevention of E. coli UTI.
Each 5 g (approx. 2½ teaspoons) contains:
Cranberry (Vaccinium macrocarpon) 400 mg
ᴅ‑Mannose 4600 mg
All ingredients listed for this product lot number have been validated by a third-party laboratory for identity, potency, and purity.
Adults: Take 5 g (approx. 2½ teaspoons) once or twice daily or as directed by your health-care practitioner.
Preservatives, artificial flavour or colour, dairy, starch, wheat, gluten, soy, corn, or yeast.